In addition, data on glioma xenograft demonstrate a reduction of the expression of the vascular endothelial growth factor (VEGF) on tumor vasculature, thus suggesting an anti-angiogenetic effect for NVP-BEZ235 (Liu et al., 2009b). Here, VEGFA is linked to glioma.